| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.31▲ | 1.31▲ | 1.31▲ | 1.29▲ | 1.33▼ |
| MA10 | 1.30▲ | 1.31▲ | 1.31▲ | 1.31▲ | 1.43▼ |
| MA20 | 1.31▲ | 1.31▲ | 1.30▲ | 1.34▼ | 1.48▼ |
| MA50 | 1.29▲ | 1.31▲ | 1.30▲ | 1.49▼ | 1.33▼ |
| MA100 | 1.30▲ | 1.32▲ | 1.34▼ | 1.45▼ | 2.25▼ |
| MA200 | 1.32▲ | 1.37▼ | 1.41▼ | 1.32▼ | 2.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.001▲ | 0.002▲ | 0.007▲ | -0.033▼ |
| RSI | 57.453▲ | 55.652▲ | 54.092▲ | 45.400▼ | 46.970▼ |
| STOCH | 55.000 | 51.195 | 50.000 | 54.688 | 10.275▼ |
| WILL %R | 0.000▲ | -9.091▲ | -9.091▲ | -46.429 | -88.372▼ |
| CCI | 113.725▲ | 74.006 | 93.468 | -35.015 | -90.723 |
|
Thursday, April 02, 2026 04:09 PM
Merck (NYSE:MRK) received European Union approval for KEYTRUDA in combination regimens for adults with platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma that is PD-L1 ...
|
|
Wednesday, April 01, 2026 11:12 PM
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Top Stocks Fund Managers Are Loading Up On in 2026. On March 30, 2026, Merck & Co., Inc. (NYSE:MRK) announced positive Phase 3 CORALreef AddOn trial ...
|
|
Wednesday, April 01, 2026 10:37 AM
Merck & Co., Inc. (NYSE:MRK) is one of the 10 top stocks fund managers are loading up on in 2026.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 1.30 | 1.33 | 1.27 | 1.32 | 94,234 |
| 01/04/26 | 1.30 | 1.35 | 1.2901 | 1.31 | 72,979 |
| 31/03/26 | 1.27 | 1.35 | 1.24 | 1.30 | 68,079 |
| 30/03/26 | 1.34 | 1.35 | 1.19 | 1.24 | 124,655 |
| 27/03/26 | 1.34 | 1.39 | 1.26 | 1.30 | 89,836 |
| 26/03/26 | 1.33 | 1.38 | 1.31 | 1.35 | 80,786 |
| 25/03/26 | 1.27 | 1.40 | 1.27 | 1.34 | 189,371 |
| 24/03/26 | 1.32 | 1.33 | 1.17 | 1.26 | 237,972 |
| 23/03/26 | 1.31 | 1.3683 | 1.25 | 1.31 | 129,007 |
| 20/03/26 | 1.32 | 1.38 | 1.27 | 1.34 | 131,457 |
|
|
||||
|
|
||||
|
|